Special Issue “Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0”
Valentina Gandin, James D. Hoeschele, Nicola Margiotta
Abstract
The year 2023 marks the 45th year since FDA approval of cisplatin as an anticancer drug, and, at present, it is widely used against a spectrum of human tumors, including early-stage ovarian cancer, non-small cell lung cancer (typically developed by smokers), head and neck, and advanced bladder cancer [...].
Topics & Concepts
CisplatinMedicineLung cancerOvarian cancerHead and neck cancerOncologyCancerBladder cancerDrugInternal medicineHead and neckBioinformaticsCancer researchPharmacologyChemotherapyBiologySurgeryMetal complexes synthesis and propertiesFerrocene Chemistry and ApplicationsCancer therapeutics and mechanisms